Dexcom shares plunge more than 40%, head for worst day on record
Dexcom, which had its stock market debut in 2005, is headed for its worst day ever after lowering its full-year guidance.
Dexcom, which had its stock market debut in 2005, is headed for its worst day ever after lowering its full-year guidance.
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research...
Dexcom shares fall on revenue miss and weak guidance
The stock's nearly 5% slide Thursday is pushing it closer to a level where we would consider buying more shares.
Shares of Dover, which has exposure to artificial intelligence and the biopharma recovery, jumped more than 6% on the report.
Though Hasbro's revenue declined 18% overall during the quarter, Wizards of the Coast and the digital gaming segment grew 20%.
Southwest is under pressure from an activist investor after it lagged competitors.
Keurig Dr Pepper's second-quarter earnings and revenue met Wall Street's expectations.
The carrier's profit fell 46% during the second quarter even though revenues rose.